Case
Here we report a rare case of a recurrent Doege-Poter Syndrome with
atypical gelatinous tumor lesions of the lung, pleura and pericardial
fat tissue in an 87-year-old woman. Although previously described as
ineffective, we demonstrate that adjuvant treatment with Octreotide in
conjunction with intravenous glucose helps to maintain tolerable blood
glucose levels before tumor resection. The somatostatin-analogue
Lanreotide was successfully used after tumor debulking surgery to
maintain adequate blood glucose control.